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Effects of Platelet-rich Plasma Injections on the Healing of Different Tissues in Athletes
Kelly Griffith
Fort Hays State University

Abstract
Sprains, strains, and tendinopathies are some of the most common injuries in athletics and each present
their own challenges for sports medicine practitioners. A new form of nonoperative treatment called
Platelet-rich plasma (PRP) injections have gained attention and consideration for treating soft tissue
injuries. PRP is a preparation of autologous human plasma with an increased platelet concentration.
When injected, the PRP releases larger amounts than normally found in the body of growth factors and
cytokines to the injury site. This is theorized to start the natural healing process. The purpose of this
study was to analyze the effects of platelet-rich plasma injections in athletes suffering from ligament,
tendon, or musculoskeletal injuries through a systematic review of literature.

Introduction
Tendinopathies often occur due to overuse of the limb. The etiology of this injury is unknown and can
have multiple predisposing factors. The prevalence of tendonitis in sports in the United States is
estimated to be about 30-50% (Ackerman & Renstrom, 2012). Muscle strains usually occur acutely in
the eccentric phase with the hamstring most often affected (Maffuli et al., 2014). Muscle injuries
account for 10 to 55% of all acute sports injuries (Maffuli et al., 2014). Ligament sprains account for
around 15-17% of sport related injuries with ankle sprains being the most common (Herzog, Kerr,
Marshall, & Wikstrom, 2019). Each tissue type presents with its own signs and symptoms, treatment
options, and time to return to play. The use of PRP injections has just recently gained traction and are
being heavily researched to prove its efficacy in healing all types of tissues in the sports community.

Methodology
A search of Pubmed, Cochran Central, Ebscohost, and
Medline was conducted with the keywords “platelet-rich
plasma injections” followed by “in athletes”. The
inclusion criteria consisted of the article analyzing the use
of PRP injections for treatment of a sprain, strain, or
tendinosis in athletes. Athletes for this review were
defined as sport playing person anywhere from 16-35
years old. The exclusion criteria were articles which used
PRP injections for non-athletes, the experiment was
conducted on animals, or the study compared the
injections to another form of treatment. Any study found
not meeting the clinically relevant question were not
considered. The methodology of each article found was
critically appraised using the PEDro appraisal scale. Any
article which scored above a five was included and any
articles which scored under a five were excluded from the
review.

Conclusion
The study analyzed new research on the overall effectiveness of platelet-rich plasma injections in the
athletic population. The available evidence showed an overall positive outcome, but some precautions
of accepting the research should be considered. More research should be conducted to solidify these
results. Once the research has proven it to be a new form of effective treatment, then it can be utilized to
aid in the healing process,, decrease pain, and decrease time to return to play.
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Results
Sources

Number of
Participants

Outcome
Measures

# of
Injections

Improved Healing and Return to Play
(RTP)?

Tendons
Charousset et al.
(2014)
Kon et al.
(2009)
Zayni et al.
(2015)

28

MRI, VAS, VISA-P
Lysholm pain scores.

20

Tegner score, EQ-VAS,
SF-36,
functional testing
VISA-P, VAS, Tegner

3

21 returned asymptomatic at 3 months. 16 out of the 21
athletes MRI’s showed improved structural integrity

3

all participants had improvements in their scores at the six
month follow up.

2 vs 1

40

Of the 30 patients, 26 of them returned to their pre-symptom
sporting level after a mean delay of 6.7 weeks. Found 2
injections to be better than 1

Muscles
A Hamid et al.
(2014)

28

Rettig et al.

Time to RTP,
Brief Pain Inventory
Short Form

2

PRP injections group achieved full recovery around 26.7± 7
days. The control group achieved full recovery around 42.5 ±
20.6 days. Lower pain scores were also observed in the PRP
injection group.

1

no significant differences between the two groups regarding
RTP. The control group returned in a median time of 17-days
the treatment group returned in a median time of 20-days.

1

the treatment group returned to play in 21.1 ± 3.1 days while
the control group returned in 25 ± 2.8 days. The pain severity
scores were also significantly lower in the PRP group

Time to RTP

10

(2013)

Rossi et al.
(2016)

75

Rostyslav et al.,
(2013)

30

Time to RTP, Pain
severity,
Reoccurrence rates
VAS, muscle function,
regeneration of tissue

1

Pain was significantly lower in PRP group and regeneration
was happening quicker than the control group.

Ligaments
Podesta et al.
(2013)

34

Deal et al.
(2017)

25

Chauhan et al.,
(2019)

544

Laver et al.,
(2015).

16
3 of 3

Time to RTP,
DASH,
and KJOC
Reconstruction via
MRA, Time
to RTP
Time to RTP,
Kaplan-Meier
Survival analysis
Time to RTP,
Tegner activity Level

1
2
1

2

30 of the 34 athletes returned to the same level of play w/o
complaints in 12 weeks. The average KJOC score improved
from a 46 to a 93. The DASH improved from a 69 to a 3.
The posttreatment MRA showed full reconstitution in 20 of
the 22 patients who successfully returned to play.
players who received PRP had a significantly longer delay in
return to throwing when compared to the other group.
However, the survival analysis did not provide significant
differences between groups.
The mean RTP for the control group was d 59.6 ± 12.0 days
treatment group had 40.8 ± 8.9 days. The pain of the
patients after RTP, only 12.5% of patients from the treatment
group experienced pain compared to 62.5% in the control
group.

